- call +1-201-465-4211
- email sales@mrinsights.biz
Type 1 diabetes (T1D) is an autoimmune disease that occurs when a person’s pancreas stops producing insulin, the hormone that controls blood-sugar levels. T1D develops when the insulin-producing pancreatic beta cells are mistakenly destroyed by the body’s immune system. The cause of this attack is still being researched, however scientists believe the cause may have genetic and environmental components.
Scope of the Report:
This report focuses on the Type 1 Diabetes (T1D) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Sedentary lifestyle, unhealthy diet, lack of exercise and increasing prevalence of diabetes are key driver for Type 1 Diabetes (T1D) market. Insulin therapy is very much essential in the patients who have type 1 diabetes. Rising launch of the novel insulin formulations along with several adjunct therapies will positively impact the insulin acceptance. On the other hand, this chronic disorder poses a significant economic impact owing to the increasing cost of insulin coupled with other conditions such as cardiac disorders, kidney disease among others. While insulin therapy keeps people with T1D alive and can help keep blood-glucose levels within recommended range, it is not a cure, nor does it prevent the possibility of T1D’s serious effects. Although T1D is a serious and challenging disease, long-term management options continue to evolve, allowing those with T1D to have full and active lives. Asia Pacific region recorded the highest growth rate over the forecast period owing to the increasingly sedentary lifestyles, obese population, and improper food habits. North America accounted for more than 50% of the total market share over the forecast period.
The worldwide market for Type 1 Diabetes (T1D) is expected to grow at a CAGR of roughly 4.4% over the next five years, will reach 2540 million US$ in 2023, from 1960 million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Novo Nordisk
Sanofi
Eli Lilly
Merck
Boehringer Ingelheim
Samsung Bioepis
Biocon
Astellas
Janssen
Bristol-Myers Squibb
Lexicon
Sanofi
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Rapid Acting Insulin Analogs
Long Acting Insulin Analogs
Premix Insulin Analogs
Market Segment by Applications, can be divided into
Children
Adults
There are 15 Chapters to deeply display the global Type 1 Diabetes (T1D) market.
Chapter 1, to describe Type 1 Diabetes (T1D) Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Type 1 Diabetes (T1D), with sales, revenue, and price of Type 1 Diabetes (T1D), in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Type 1 Diabetes (T1D), for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Type 1 Diabetes (T1D) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Type 1 Diabetes (T1D) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Type 1 Diabetes (T1D) Introduction
1.2 Market Analysis by Type
1.2.1 Rapid Acting Insulin Analogs
1.2.2 Long Acting Insulin Analogs
1.2.3 Premix Insulin Analogs
1.3 Market Analysis by Applications
1.3.1 Children
1.3.2 Adults
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novo Nordisk
2.1.1 Business Overview
2.1.1.1 Novo Nordisk Description
2.1.1.2 Novo Nordisk Headquarter, Main Business and Finance Overview
2.1.2 Novo Nordisk Type 1 Diabetes (T1D) Product Introduction
2.1.2.1 Type 1 Diabetes (T1D) Production Bases, Sales Regions and Major Competitors
2.1.2.2 Type 1 Diabetes (T1D) Product Information
2.1.3 Novo Nordisk Type 1 Diabetes (T1D) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Novo Nordisk Type 1 Diabetes (T1D) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Novo Nordisk Type 1 Diabetes (T1D) Market Share in 2017
2.2 Sanofi
2.2.1 Business Overview
2.2.1.1 Sanofi Description
2.2.1.2 Sanofi Headquarter, Main Business and Finance Overview
2.2.2 Sanofi Type 1 Diabetes (T1D) Product Introduction
2.2.2.1 Type 1 Diabetes (T1D) Production Bases, Sales Regions and Major Competitors
2.2.2.2 Type 1 Diabetes (T1D) Product Information
2.2.3 Sanofi Type 1 Diabetes (T1D) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Sanofi Type 1 Diabetes (T1D) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Sanofi Type 1 Diabetes (T1D) Market Share in 2017
2.3 Eli Lilly
2.3.1 Business Overview
2.3.1.1 Eli Lilly Description
2.3.1.2 Eli Lilly Headquarter, Main Business and Finance Overview
2.3.2 Eli Lilly Type 1 Diabetes (T1D) Product Introduction
2.3.2.1 Type 1 Diabetes (T1D) Production Bases, Sales Regions and Major Competitors
2.3.2.2 Type 1 Diabetes (T1D) Product Information
2.3.3 Eli Lilly Type 1 Diabetes (T1D) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Eli Lilly Type 1 Diabetes (T1D) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Eli Lilly Type 1 Diabetes (T1D) Market Share in 2017
2.4 Merck
2.4.1 Business Overview
2.4.1.1 Merck Description
2.4.1.2 Merck Headquarter, Main Business and Finance Overview
2.4.2 Merck Type 1 Diabetes (T1D) Product Introduction
2.4.2.1 Type 1 Diabetes (T1D) Production Bases, Sales Regions and Major Competitors
2.4.2.2 Type 1 Diabetes (T1D) Product Information
2.4.3 Merck Type 1 Diabetes (T1D) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Merck Type 1 Diabetes (T1D) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Merck Type 1 Diabetes (T1D) Market Share in 2017
2.5 Boehringer Ingelheim
2.5.1 Business Overview
2.5.1.1 Boehringer Ingelheim Description
2.5.1.2 Boehringer Ingelheim Headquarter, Main Business and Finance Overview
2.5.2 Boehringer Ingelheim Type 1 Diabetes (T1D) Product Introduction
2.5.2.1 Type 1 Diabetes (T1D) Production Bases, Sales Regions and Major Competitors
2.5.2.2 Type 1 Diabetes (T1D) Product Information
2.5.3 Boehringer Ingelheim Type 1 Diabetes (T1D) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Boehringer Ingelheim Type 1 Diabetes (T1D) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Boehringer Ingelheim Type 1 Diabetes (T1D) Market Share in 2017
2.6 Samsung Bioepis
2.6.1 Business Overview
2.6.1.1 Samsung Bioepis Description
2.6.1.2 Samsung Bioepis Headquarter, Main Business and Finance Overview
2.6.2 Samsung Bioepis Type 1 Diabetes (T1D) Product Introduction
2.6.2.1 Type 1 Diabetes (T1D) Production Bases, Sales Regions and Major Competitors
2.6.2.2 Type 1 Diabetes (T1D) Product Information
2.6.3 Samsung Bioepis Type 1 Diabetes (T1D) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Samsung Bioepis Type 1 Diabetes (T1D) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Samsung Bioepis Type 1 Diabetes (T1D) Market Share in 2017
2.7 Biocon
2.7.1 Business Overview
2.7.1.1 Biocon Description
2.7.1.2 Biocon Headquarter, Main Business and Finance Overview
2.7.2 Biocon Type 1 Diabetes (T1D) Product Introduction
2.7.2.1 Type 1 Diabetes (T1D) Production Bases, Sales Regions and Major Competitors
2.7.2.2 Type 1 Diabetes (T1D) Product Information
2.7.3 Biocon Type 1 Diabetes (T1D) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Biocon Type 1 Diabetes (T1D) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Biocon Type 1 Diabetes (T1D) Market Share in 2017
2.8 Astellas
2.8.1 Business Overview
2.8.1.1 Astellas Description
2.8.1.2 Astellas Headquarter, Main Business and Finance Overview
2.8.2 Astellas Type 1 Diabetes (T1D) Product Introduction
2.8.2.1 Type 1 Diabetes (T1D) Production Bases, Sales Regions and Major Competitors
2.8.2.2 Type 1 Diabetes (T1D) Product Information
2.8.3 Astellas Type 1 Diabetes (T1D) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Astellas Type 1 Diabetes (T1D) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Astellas Type 1 Diabetes (T1D) Market Share in 2017
2.9 Janssen
2.9.1 Business Overview
2.9.1.1 Janssen Description
2.9.1.2 Janssen Headquarter, Main Business and Finance Overview
2.9.2 Janssen Type 1 Diabetes (T1D) Product Introduction
2.9.2.1 Type 1 Diabetes (T1D) Production Bases, Sales Regions and Major Competitors
2.9.2.2 Type 1 Diabetes (T1D) Product Information
2.9.3 Janssen Type 1 Diabetes (T1D) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Janssen Type 1 Diabetes (T1D) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Janssen Type 1 Diabetes (T1D) Market Share in 2017
2.10 Bristol-Myers Squibb
2.10.1 Business Overview
2.10.1.1 Bristol-Myers Squibb Description
2.10.1.2 Bristol-Myers Squibb Headquarter, Main Business and Finance Overview
2.10.2 Bristol-Myers Squibb Type 1 Diabetes (T1D) Product Introduction
2.10.2.1 Type 1 Diabetes (T1D) Production Bases, Sales Regions and Major Competitors
2.10.2.2 Type 1 Diabetes (T1D) Product Information
2.10.3 Bristol-Myers Squibb Type 1 Diabetes (T1D) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Bristol-Myers Squibb Type 1 Diabetes (T1D) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Bristol-Myers Squibb Type 1 Diabetes (T1D) Market Share in 2017
2.11 Lexicon
2.11.1 Business Overview
2.11.2 Lexicon Type 1 Diabetes (T1D) Product Introduction
2.11.3 Lexicon Type 1 Diabetes (T1D) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Sanofi
2.12.1 Business Overview
2.12.2 Sanofi Type 1 Diabetes (T1D) Product Introduction
2.12.3 Sanofi Type 1 Diabetes (T1D) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Type 1 Diabetes (T1D) Market Competition, by Manufacturer
3.1 Global Type 1 Diabetes (T1D) Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Type 1 Diabetes (T1D) Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Type 1 Diabetes (T1D) Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Type 1 Diabetes (T1D) Manufacturer Market Share in 2017
3.4.2 Top 5 Type 1 Diabetes (T1D) Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Type 1 Diabetes (T1D) Market Analysis by Regions
4.1 Global Type 1 Diabetes (T1D) Sales, Revenue and Market Share by Regions
4.1.1 Global Type 1 Diabetes (T1D) Sales by Regions (2013-2018)
4.1.2 Global Type 1 Diabetes (T1D) Revenue by Regions (2013-2018)
4.2 North America Type 1 Diabetes (T1D) Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Type 1 Diabetes (T1D) Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Type 1 Diabetes (T1D) Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Type 1 Diabetes (T1D) Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Type 1 Diabetes (T1D) Sales, Revenue and Growth Rate (2013-2018)
5 North America Type 1 Diabetes (T1D) by Countries, Type, Application and Manufacturers
5.1 North America Type 1 Diabetes (T1D) Sales, Revenue and Market Share by Countries
5.1.1 North America Type 1 Diabetes (T1D) Sales by Countries (2013-2018)
5.1.2 North America Type 1 Diabetes (T1D) Revenue by Countries (2013-2018)
5.1.3 United States Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)
5.1.4 Canada Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)
5.1.5 Mexico Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)
5.2 North America Type 1 Diabetes (T1D) Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Type 1 Diabetes (T1D) Sales by Manufacturers (2016-2017)
5.2.2 North America Type 1 Diabetes (T1D) Revenue by Manufacturers (2016-2017)
5.3 North America Type 1 Diabetes (T1D) Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Type 1 Diabetes (T1D) Sales and Sales Share by Type (2013-2018)
5.3.2 North America Type 1 Diabetes (T1D) Revenue and Revenue Share by Type (2013-2018)
5.4 North America Type 1 Diabetes (T1D) Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Type 1 Diabetes (T1D) Sales and Sales Share by Application (2013-2018)
5.4.2 North America Type 1 Diabetes (T1D) Revenue and Revenue Share by Application (2013-2018)
6 Europe Type 1 Diabetes (T1D) by Countries, Type, Application and Manufacturers
6.1 Europe Type 1 Diabetes (T1D) Sales, Revenue and Market Share by Countries
6.1.1 Europe Type 1 Diabetes (T1D) Sales by Countries (2013-2018)
6.1.2 Europe Type 1 Diabetes (T1D) Revenue by Countries (2013-2018)
6.1.3 Germany Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)
6.1.4 UK Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)
6.1.5 France Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)
6.1.6 Russia Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)
6.1.7 Italy Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)
6.2 Europe Type 1 Diabetes (T1D) Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Type 1 Diabetes (T1D) Sales by Manufacturers (2016-2017)
6.2.2 Europe Type 1 Diabetes (T1D) Revenue by Manufacturers (2016-2017)
6.3 Europe Type 1 Diabetes (T1D) Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Type 1 Diabetes (T1D) Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Type 1 Diabetes (T1D) Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Type 1 Diabetes (T1D) Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Type 1 Diabetes (T1D) Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Type 1 Diabetes (T1D) Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Type 1 Diabetes (T1D) by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Type 1 Diabetes (T1D) Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Type 1 Diabetes (T1D) Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Type 1 Diabetes (T1D) Revenue by Countries (2013-2018)
7.1.3 China Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)
7.1.4 Japan Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)
7.1.5 Korea Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)
7.1.6 India Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Type 1 Diabetes (T1D) Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Type 1 Diabetes (T1D) Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Type 1 Diabetes (T1D) Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Type 1 Diabetes (T1D) Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Type 1 Diabetes (T1D) Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Type 1 Diabetes (T1D) Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Type 1 Diabetes (T1D) Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Type 1 Diabetes (T1D) Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Type 1 Diabetes (T1D) Revenue and Revenue Share by Application (2013-2018)
8 South America Type 1 Diabetes (T1D) by Countries, Type, Application and Manufacturers
8.1 South America Type 1 Diabetes (T1D) Sales, Revenue and Market Share by Countries
8.1.1 South America Type 1 Diabetes (T1D) Sales by Countries (2013-2018)
8.1.2 South America Type 1 Diabetes (T1D) Revenue by Countries (2013-2018)
8.1.3 Brazil Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)
8.1.4 Argentina Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)
8.1.5 Colombia Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)
8.2 South America Type 1 Diabetes (T1D) Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Type 1 Diabetes (T1D) Sales by Manufacturers (2016-2017)
8.2.2 South America Type 1 Diabetes (T1D) Revenue by Manufacturers (2016-2017)
8.3 South America Type 1 Diabetes (T1D) Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Type 1 Diabetes (T1D) Sales and Sales Share by Type (2013-2018)
8.3.2 South America Type 1 Diabetes (T1D) Revenue and Revenue Share by Type (2013-2018)
8.4 South America Type 1 Diabetes (T1D) Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Type 1 Diabetes (T1D) Sales and Sales Share by Application (2013-2018)
8.4.2 South America Type 1 Diabetes (T1D) Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Type 1 Diabetes (T1D) by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Type 1 Diabetes (T1D) Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Type 1 Diabetes (T1D) Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Type 1 Diabetes (T1D) Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)
9.1.4 UAE Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)
9.1.5 Egypt Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)
9.1.7 South Africa Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Type 1 Diabetes (T1D) Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Type 1 Diabetes (T1D) Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Type 1 Diabetes (T1D) Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Type 1 Diabetes (T1D) Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Type 1 Diabetes (T1D) Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Type 1 Diabetes (T1D) Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Type 1 Diabetes (T1D) Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Type 1 Diabetes (T1D) Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Type 1 Diabetes (T1D) Revenue and Revenue Share by Application (2013-2018)
10 Global Type 1 Diabetes (T1D) Market Segment by Type
10.1 Global Type 1 Diabetes (T1D) Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Type 1 Diabetes (T1D) Sales and Market Share by Type (2013-2018)
10.1.2 Global Type 1 Diabetes (T1D) Revenue and Market Share by Type (2013-2018)
10.2 Rapid Acting Insulin Analogs Sales Growth and Price
10.2.1 Global Rapid Acting Insulin Analogs Sales Growth (2013-2018)
10.2.2 Global Rapid Acting Insulin Analogs Price (2013-2018)
10.3 Long Acting Insulin Analogs Sales Growth and Price
10.3.1 Global Long Acting Insulin Analogs Sales Growth (2013-2018)
10.3.2 Global Long Acting Insulin Analogs Price (2013-2018)
10.4 Premix Insulin Analogs Sales Growth and Price
10.4.1 Global Premix Insulin Analogs Sales Growth (2013-2018)
10.4.2 Global Premix Insulin Analogs Price (2013-2018)
11 Global Type 1 Diabetes (T1D) Market Segment by Application
11.1 Global Type 1 Diabetes (T1D) Sales Market Share by Application (2013-2018)
11.2 Children Sales Growth (2013-2018)
11.3 Adults Sales Growth (2013-2018)
12 Type 1 Diabetes (T1D) Market Forecast (2018-2023)
12.1 Global Type 1 Diabetes (T1D) Sales, Revenue and Growth Rate (2018-2023)
12.2 Type 1 Diabetes (T1D) Market Forecast by Regions (2018-2023)
12.2.1 North America Type 1 Diabetes (T1D) Market Forecast (2018-2023)
12.2.2 Europe Type 1 Diabetes (T1D) Market Forecast (2018-2023)
12.2.3 Asia-Pacific Type 1 Diabetes (T1D) Market Forecast (2018-2023)
12.2.4 South America Type 1 Diabetes (T1D) Market Forecast (2018-2023)
12.2.5 Middle East and Africa Type 1 Diabetes (T1D) Market Forecast (2018-2023)
12.3 Type 1 Diabetes (T1D) Market Forecast by Type (2018-2023)
12.3.1 Global Type 1 Diabetes (T1D) Sales Forecast by Type (2018-2023)
12.3.2 Global Type 1 Diabetes (T1D) Market Share Forecast by Type (2018-2023)
12.4 Type 1 Diabetes (T1D) Market Forecast by Application (2018-2023)
12.4.1 Global Type 1 Diabetes (T1D) Sales Forecast by Application (2018-2023)
12.4.2 Global Type 1 Diabetes (T1D) Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Type 1 Diabetes (T1D) Picture
Table Product Specifications of Type 1 Diabetes (T1D)
Figure Global Type 1 Diabetes (T1D) CAGR (%), Y-o-Y Growth (&) and Market Size, 2
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
